Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cbd Life Sciences Inc
CBDL
Consumer Cyclical
Specialty Retail
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCPK:CBDL)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
Next
(2)
•••
AveragePenny
X
View Profile
View Bullboard History
Post by
AveragePenny
on Oct 20, 2022 10:24am
CBD Life Sciences, Inc. (CBDL) Announces Mobile CBD
SCOTTSDALE, AZ / ACCESSWIRE / October 20, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company is developing a
...more
(2)
•••
AveragePenny
X
View Profile
View Bullboard History
Post by
AveragePenny
on Sep 21, 2022 10:20am
CBD Life Sciences, Inc. (CBDL) Announces Bladder Control
SCOTTSDALE, AZ / ACCESSWIRE / September 21, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company is working
...more
(2)
•••
AveragePenny
X
View Profile
View Bullboard History
Post by
AveragePenny
on Aug 18, 2022 10:17am
CBD Life Sciences, Inc. (CBDL) Distributes NEW Infused Gummy
SCOTTSDALE, AZ / ACCESSWIRE / August 18, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company is taking an
...more
(2)
•••
AveragePenny
X
View Profile
View Bullboard History
Post by
AveragePenny
on Jul 14, 2022 10:20am
CBD Life Sciences, Inc. (CBDL) Confirms the Launching
SCOTTSDALE, AZ / ACCESSWIRE / July 14, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company is proud to launch
...more
(2)
•••
AveragePenny
X
View Profile
View Bullboard History
Post by
AveragePenny
on Jun 30, 2022 12:17pm
$CBDL Announces New Laboratory Operation Launched at CBD
SCOTTSDALE, AZ / ACCESSWIRE / June 30, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company has begun starting
...more
(13)
•••
slowandeasy
X
View Profile
View Bullboard History
Post by
slowandeasy
on Jun 20, 2022 10:02am
Total roll of the dice.
Hemp will skyrocket no doubt. Which pennies will come out on top. CBDL is one of my picks. GTEH another. A few others. Good luck all.
(2)
•••
AveragePenny
X
View Profile
View Bullboard History
Post by
AveragePenny
on May 19, 2022 11:11am
CBD Life Sciences, Inc. (CBDL) Set to Attend White Label
SCOTTSDALE, AZ / ACCESSWIRE / May 19, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announced today that the company is set to attend the
...more
Prev
1
2
3
4
5
6
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Do you want to stay ahead of the markets? See how DealRoom can help.
Debt-Free Cannabis Company Set for Next Stage of Growth
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
Learn How this Company is Disrupting Point-of-Care Testing
Why Dozens of Pro Athletes are Paying Attention to this Product